Evaluation of a Novel Antiplatelet Therapy Strategy in Patients Undergoing Elective Percutaneous Coronary Intervention

Dietmar Trenk, Gregg W. Stone, Meinrad Gawaz, Adnan Kastrati, Dominick J. Angiolillo, Ulrike Müller, Gert Richardt, Joseph A. Jakubowski, Franz-Josef Neumann, A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents: Results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) Study Journal of the American College of Cardiology. ,vol. 59, pp. 2159- 2164 ,(2012) , 10.1016/J.JACC.2012.02.026

Gennaro Sardella, Simone Calcagno, Massimo Mancone, Luigi Lucisano, Mauro Pennacchi, Rocco Edoardo Stio, Filippo Placentino, Angelo Di Roma, Erika Cavallo, Raffaele Palmirotta, Fiorella Guadagni, Francesco Fedele, Comparison of therapy with Ticagrelor, Prasugrel or high Clopidogrel dose in PCI patients with high on treatment platelet reactivity and genotype variation. TRIPLETE RESET trial. International Journal of Cardiology. ,vol. 194, pp. 60- 62 ,(2015) , 10.1016/J.IJCARD.2015.05.085

Paul P. Dobesh, Julie H. Oestreich, Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety Pharmacotherapy. ,vol. 34, pp. 1077- 1090 ,(2014) , 10.1002/PHAR.1477

José Luis Ferreiro, Dominick J. Angiolillo, New Directions in Antiplatelet Therapy Circulation-cardiovascular Interventions. ,vol. 5, pp. 433- 445 ,(2012) , 10.1161/CIRCINTERVENTIONS.111.966176

Nicola Ferri, Alberto Corsini, Stefano Bellosta, Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties. Drugs. ,vol. 73, pp. 1681- 1709 ,(2013) , 10.1007/S40265-013-0126-Z

Akshay Bagai, Doson Chua, Eric A Cohen, Jacqueline Saw, Subodh Verma, Ram Vijayaraghavan, Robert Welsh, David Fitchett, Pharmacodynamic and clinical implications of switching between P2Y12 receptor antagonists: considerations for practice. Critical pathways in cardiology. ,vol. 13, pp. 156- 158 ,(2014) , 10.1097/HPC.0000000000000030

Steven R. Steinhubl, Peter B. Berger, J. Tift Mann III, Edward T. A. Fry, Augustin DeLago, Charles Wilmer, Eric J. Topol, for the CREDO Investigators, Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. ,vol. 288, pp. 2411- 2420 ,(2002) , 10.1001/JAMA.288.19.2411

Harrington RA Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Thorsén M. PLATO Investigators, Freij A, None, Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes The New England Journal of Medicine. ,vol. 361, pp. 1045- 1057 ,(2009) , 10.1056/NEJMOA0904327

Marc P Bonaca, Deepak L Bhatt, Marc Cohen, Philippe Gabriel Steg, Robert F Storey, Eva C Jensen, Giulia Magnani, Sameer Bansilal, M Polly Fish, Kyungah Im, Olof Bengtsson, Ton Oude Ophuis, Andrzej Budaj, Pierre Theroux, Mikhail Ruda, Christian Hamm, Shinya Goto, Jindrich Spinar, Jose Carlos Nicolau, Robert G Kiss, Sabina A Murphy, Stephen D Wiviott, Peter Held, Eugene Braunwald, Marc S Sabatine, None, Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction The New England Journal of Medicine. ,vol. 372, pp. 1791- 1800 ,(2015) , 10.1056/NEJMOA1500857

Zuzana Motovska, Joseph A. Jakubowski, Guillaume Cayla, Luigi Oltrona Visconti, Eric Vicaut, Petr Widimsky, Gilles Montalescot, Leonardo Bolognese, Dariusz Dudek, Patrick Goldstein, Christian Hamm, Jean-Francois Tanguay, Jurrien M. ten Berg, Debra L. Miller, Timothy M. Costigan, Jochen Goedicke, Johanne Silvain, Paolo Angioli, Jacek Legutko, Margit Niethammer, Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes The New England Journal of Medicine. ,vol. 369, pp. 999- 1010 ,(2013) , 10.1056/NEJMOA1308075